Serum sFasL concentrations and mortality prediction in patients with sepsis
Infect Dis (Lond)
.
2021 Aug;53(8):643-646.
doi: 10.1080/23744235.2021.1901982.
Epub 2021 Mar 24.
Authors
Leonardo Lorente
1
,
María M Martín
2
,
Raquel Ortiz-López
3
,
Antonia Pérez-Cejas
4
,
Carmen Ferrer-Moure
5
,
Adriana González-Mesa
1
,
Alejandro Jiménez
6
,
Agustín F González-Rivero
5
Affiliations
1
Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
2
Intensive Care Unit, Hospital Universitario Nuestra Señora Candelaria, Santa Cruz, Tenerife, Spain.
3
Intensive Care Unit, Hospital General de La Palma, La Palma, Spain.
4
Laboratory Department, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
5
Laboratory Department, Hospital Universitario de Canarias, Santa Cruz de, Tenerife, Spain.
6
Research Unit, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
PMID:
33760686
DOI:
10.1080/23744235.2021.1901982
No abstract available
Publication types
Letter
MeSH terms
Enzyme-Linked Immunosorbent Assay
Fas Ligand Protein
Humans
Sepsis*
Substances
Fas Ligand Protein